You are viewing a free preview of this lesson.
Subscribe to unlock all 10 lessons in this course and every other course on LearningBro.
Obsessive-Compulsive Disorder (OCD) is an anxiety-related condition defined by two linked features: obsessions — recurrent, intrusive thoughts, images or urges that generate anxiety — and compulsions — repetitive behaviours or mental acts the person feels driven to perform in an attempt to reduce that anxiety. The AQA specification uses OCD as the worked example for the biological approach to explaining and treating a disorder, set against a cognitive account, so the core skill is to describe genetic and neural explanations and drug therapy precisely (AO1) and to evaluate them rigorously (AO3), including the perennial issues of causation, reductionism and the gene-environment interaction. As with all clinical content, OCD is discussed here in a measured, academic register — as a condition to be explained and treated — rather than described in a way that could distress or instruct.
Key Definition: Obsessive-Compulsive Disorder (OCD) is a condition characterised by obsessions (recurrent, unwanted, intrusive thoughts, images or urges that cause marked anxiety) and compulsions (repetitive behaviours or mental acts performed in response to obsessions, according to rigid rules, to reduce anxiety or prevent a feared outcome).
This lesson covers the AQA 7182 Paper 1 Psychopathology requirement: the biological approach to explaining and treating OCD, alongside the characteristics of the disorder. For AO1 you must be able to describe the genetic explanation (candidate genes including COMT and SERT; the polygenic nature of OCD; family/twin evidence in the tradition of Lewis's findings), the neural explanation (the role of the basal ganglia and orbitofrontal cortex, and the serotonin system), and the biological therapy of SSRIs (e.g. fluoxetine). For AO3 you must evaluate this approach for the strength of its genetic and neural evidence, the correlation-versus-causation problem, biological reductionism, the gene-environment interaction, and the effectiveness and ethics of drug therapy. The cognitive explanation is included for comparison and for the diathesis-stress synthesis. The lesson parallels the cognitive account of depression in the previous lesson, enabling direct cross-disorder comparison of explanations and treatments.
OCD is characterised across three response systems.
| Component | Characteristics |
|---|---|
| Behavioural | Compulsions — repetitive acts (e.g. washing, checking, counting, ordering) performed to reduce anxiety; these are excessive and not realistically connected to the feared outcome. Avoidance of situations that trigger obsessions is also common. |
| Emotional | Persistent anxiety and distress; accompanying feelings of guilt, disgust or shame; marked discomfort if a compulsion is resisted |
| Cognitive | Obsessions — recurrent, intrusive, unwanted thoughts the person recognises as excessive but cannot dismiss; catastrophic appraisals of what will happen if compulsions are not performed; selective attention to the perceived threat |
Key Definition: Obsessions are recurrent, intrusive thoughts, images or urges experienced as unwanted and distressing. Compulsions are repetitive behaviours or mental acts the person feels driven to perform in response, to reduce anxiety or prevent a dreaded event.
A central point for the exam is the obsession-compulsion cycle: an intrusive obsession generates anxiety; performing a compulsion produces temporary relief; that relief reinforces the compulsion; but the underlying obsession returns, so the cycle repeats and intensifies over time. The most common presentations pair a characteristic obsession with a characteristic compulsion, and being able to give an example is useful for the characteristics part of an answer.
| Obsession theme | Typical obsession | Associated compulsion |
|---|---|---|
| Contamination | Concern about germs or dirt | Repeated washing or cleaning; avoidance of "contaminated" objects |
| Harm/responsibility | Fear that one might cause harm through negligence | Repeated checking (e.g. that an appliance is off) |
| Symmetry/order | Need for things to feel "just right" or balanced | Arranging, ordering, counting |
| Forbidden thoughts | Unwanted taboo intrusions the person finds repugnant | Covert mental rituals (e.g. silently repeating phrases) to neutralise the thought |
It is also worth noting, for evaluation, that OCD shows a degree of cultural and historical consistency in its core features while the content of obsessions reflects context — a point relevant to whether the disorder is best explained biologically (universal mechanism) or partly through learning and culture (variable content).
The biological approach explains OCD as arising from genetic vulnerability expressed through neural and neurochemical abnormalities — in short, OCD runs in families because inherited genes shape brain systems that, when dysfunctional, produce obsessions and compulsions.
OCD shows clear familial clustering. Early family research in the tradition of Lewis (1936), who observed that a substantial proportion of his OCD patients had a parent or sibling with the disorder, established that OCD runs in families, and later twin studies show higher concordance in monozygotic (identical) than dizygotic (non-identical) twins, consistent with a heritable component.
Crucially, OCD is polygenic — many genes each contribute a small amount of risk rather than a single "OCD gene" — and it may be aetiologically heterogeneous, meaning different combinations of genes produce OCD in different people. Two well-studied candidate genes are highlighted by the specification:
| Candidate gene | What it codes for | Proposed role in OCD |
|---|---|---|
| COMT | The enzyme catechol-O-methyltransferase, which breaks down dopamine | A lower-activity variant is associated with less dopamine breakdown and so higher dopamine activity, linked to OCD |
| SERT (5-HTT) | The serotonin transporter responsible for serotonin reuptake | Variants associated with reduced serotonin activity in the synapse, linked to OCD symptoms |
The genetic vulnerability is thought to be expressed through abnormalities in a specific frontal-striatal circuit and in the serotonin system.
| Brain region | Normal function | Proposed abnormality in OCD |
|---|---|---|
| Orbitofrontal cortex (OFC) | Sends "worry"/error signals when something seems wrong; involved in decision-making | Heightened activity, generating excessive signals that something is wrong, experienced as obsessions |
| Basal ganglia (incl. caudate nucleus) | Filters/ suppresses minor "worry" signals before they reach the cortex | Dysfunction, failing to filter the signals so they reach the cortex repeatedly, driving the obsession-compulsion loop |
The serotonin hypothesis proposes that low serotonin activity disrupts the normal transmission of mood-relevant signals in this circuit and contributes to OCD; its main support is that SSRIs, which raise synaptic serotonin, reduce OCD symptoms. A useful supporting study is Menzies et al. (2008), who found that OCD patients and their unaffected first-degree relatives showed reduced grey matter in regions including the OFC compared with controls, implying an inherited neural vulnerability rather than a consequence of the illness alone.
graph TD
GENES[Genetic vulnerability<br/>polygenic: COMT, SERT, others] --> NEURO[Atypical neural development]
NEURO --> OFC[Orbitofrontal cortex:<br/>heightened worry/error signals]
NEURO --> BG[Basal ganglia:<br/>fails to filter the signals]
NEURO --> SERO[Low serotonin in the circuit]
OFC --> OBS[Obsessions: persistent sense something is wrong]
BG --> OBS
SERO --> OBS
OBS --> COMP[Compulsions to reduce anxiety]
COMP --> RELIEF[Temporary relief reinforces compulsion]
RELIEF -.-> OBS
The first-line biological treatment for OCD is drug therapy, principally Selective Serotonin Reuptake Inhibitors (SSRIs).
SSRIs block the reuptake of serotonin from the synaptic cleft back into the presynaptic neuron, so serotonin remains in the synapse for longer and stimulates the postsynaptic receptor more. Because low serotonin activity is implicated in OCD, prolonging serotonin's action is thought to normalise transmission in the OFC-basal ganglia circuit and reduce symptoms. Common examples include fluoxetine, sertraline and fluvoxamine; doses for OCD are often higher than for depression, and full effects typically take several weeks. SSRIs are frequently combined with CBT, and where SSRIs are insufficient a tricyclic such as clomipramine may be used as an alternative.
A standard supporting reference is Soomro et al. (2008), a meta-analysis of randomised controlled trials, which found SSRIs significantly more effective than placebo in reducing OCD symptoms.
The cognitive approach offers a contrasting account: that OCD arises from the catastrophic misinterpretation of normal intrusive thoughts. Most people experience occasional intrusive thoughts and dismiss them as meaningless; on this view, people with OCD instead appraise such thoughts as highly significant and threatening — through cognitive distortions such as thought-action fusion (believing that thinking about an event is morally equivalent to doing it, or makes it more likely), inflated responsibility, and intolerance of uncertainty — which drives compulsions to neutralise the perceived threat. The associated therapy, CBT with Exposure and Response Prevention (ERP), exposes the person to the trigger while preventing the compulsion, so anxiety habituates and the person learns the feared outcome does not occur. This account and therapy are included here to enable comparison with the biological approach and to support the diathesis-stress synthesis below.
Because OCD is the specification's set-piece for the biological approach but is also explicable cognitively, a clear comparison is examinable and underpins the integrative conclusion.
| Feature | Biological approach | Cognitive approach |
|---|---|---|
| Proposed cause | Inherited vulnerability expressed via neural/neurochemical abnormality | Catastrophic misinterpretation of normal intrusive thoughts |
| Treatment | Drug therapy (SSRIs) | CBT with ERP |
| Focus | Genes, brain circuitry, serotonin | Appraisals and maintaining behaviours |
| Determinism | Biologically deterministic ("nature") | Allows the person some agency over appraisals |
| Key strength | Strong heritability and imaging evidence; effective, low-effort drug treatment | Addresses the disorder's cognitions directly; durable, empowering treatment |
| Key limitation | Reductionist; correlational; treats symptoms | Less clear about ultimate origin; demanding for the client |
Rather than treating these as rival theories, the most defensible position integrates them in a diathesis-stress (biopsychosocial) framework: a biological vulnerability (heritable neural and serotonergic differences) is activated by stressors (life events) and maintained by cognitive factors (thought-action fusion, inflated responsibility) and by the negatively reinforced obsession-compulsion cycle. This integration explains why combined treatment — SSRIs to dampen the neurochemical contribution plus CBT-ERP to dismantle the cognitive-behavioural maintenance — is frequently more effective than either alone, and it is the synthesis that top-band answers are expected to reach.
The genetic explanation is well supported by family and twin evidence, but the data fall short of proving genetic determinism. Family studies in the tradition of Lewis, and the consistent finding of higher concordance in monozygotic than dizygotic twins, point clearly to a heritable contribution, which is a real strength of the genetic account. However, monozygotic concordance is well below 100%, which is decisive: if OCD were purely genetic, identical twins sharing all their genes would always share the disorder, and they do not. The implication is that genes confer vulnerability rather than certainty, and that environmental factors must also contribute — so the genetic explanation is best understood as one component of a diathesis-stress account rather than a complete cause.
The polygenic and heterogeneous nature of OCD both supports and complicates the genetic explanation. Identifying candidate genes such as COMT and SERT lends mechanistic plausibility, and the polygenic model fits the observation that no single gene reliably produces OCD. Yet because many genes each exert only a tiny effect, and because different gene combinations may produce OCD in different people (aetiological heterogeneity), the explanation has limited predictive power for any individual and is difficult to test definitively. This matters because it tempers the apparent precision of naming specific genes: the genetic account explains that OCD is heritable far more securely than it explains how, and current genetic findings account for only part of the heritability.
The neural explanation is corroborated by converging imaging and pharmacological evidence, which strengthens it considerably. Brain-imaging work implicating heightened OFC activity and basal-ganglia dysfunction, the effectiveness of serotonin-acting drugs, and Menzies et al.'s finding of shared grey-matter differences in patients and their unaffected relatives, together build a reasonably coherent picture of a frontal-striatal circuit abnormality with a genetic basis. The convergence of independent methods on the same circuit is precisely the kind of triangulation that warrants confidence. The implication is that the neural account is among the better-evidenced biological explanations of any disorder, even if, as below, the evidence cannot establish causal direction.
Subscribe to continue reading
Get full access to this lesson and all 10 lessons in this course.